These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 7103445)
21. Antibiotic prophylaxis for cardiovascular surgery. Efficacy with coronary artery bypass. Platt R; Muñoz A; Stella J; VanDevanter S; Koster JK Ann Intern Med; 1984 Dec; 101(6):770-4. PubMed ID: 6388452 [TBL] [Abstract][Full Text] [Related]
22. Ceforanide vs. cephalothin concentrations in total joint arthroplasty. Cady WJ; Wulf BG; O'Neil MT; Burney DW; Hamsa WR Drug Intell Clin Pharm; 1983 Sep; 17(9):645-8. PubMed ID: 6617484 [TBL] [Abstract][Full Text] [Related]
23. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime. Tartaglione TA; Polk RE Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304 [TBL] [Abstract][Full Text] [Related]
24. Concentration of cefamandole in plasma and tissues of patients undergoing cardiac surgery: the influence of different cefamandole dosage. Menges T; Sablotzki A; Welters I; Wagner RM; Zickmann B; Gronau S; Demirbelek G; Görlach G; Hempelmann G J Cardiothorac Vasc Anesth; 1997 Aug; 11(5):565-70. PubMed ID: 9263086 [TBL] [Abstract][Full Text] [Related]
25. A comparison of the penetration characteristics of cephapirin and cephalothin into right atrial appendage, muscle, fat, and pericardial fluid of pediatric patients undergoing open-heart operation. Green ER; Subramanian S; Faden H; Quintiliani R; Nightingale CH Ann Thorac Surg; 1981 Feb; 31(2):155-60. PubMed ID: 7458486 [TBL] [Abstract][Full Text] [Related]
27. [Plasma and tissue concentrations of cefamandole during cardiac surgery]. Clavey M; Weber M; Hubert T; Delanoë B; Poussot C; Hottier E; Villemot JP Ann Fr Anesth Reanim; 1989; 8(4):316-20. PubMed ID: 2817542 [TBL] [Abstract][Full Text] [Related]
28. A comparison of the safety, efficacy, and distribution of ceforanide and cephalothin in coronary artery bypass graft surgery. Raab TA; Balderman S; Bhayana J; Bingham K; Mylotte J; Beam TR Ann Thorac Surg; 1982 Apr; 33(4):340-4. PubMed ID: 7041840 [TBL] [Abstract][Full Text] [Related]
29. Comparison of cefamandole and cefazolin during cardiopulmonary bypass. Bryan CS; Smith CW; Sutton JP; Allen WB; Blanding R; Gangemi JD J Thorac Cardiovasc Surg; 1983 Aug; 86(2):222-5. PubMed ID: 6348425 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis. Cooper RH; Savitch CB; Joseph WP; Mills J Antimicrob Agents Chemother; 1981 Feb; 19(2):256-9. PubMed ID: 7347561 [TBL] [Abstract][Full Text] [Related]
31. Comparative study between two prophylactic antibiotic regimens of cefamandole during coronary artery bypass surgery. van der Starre PJ; Trienekens PH; Harinck-de Weerd JE; Willems FT; Kootstra GJ; Huige PJ; Quik RF Ann Thorac Surg; 1988 Jan; 45(1):24-7. PubMed ID: 3257375 [TBL] [Abstract][Full Text] [Related]
32. Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Campoli-Richards DM; Lackner TE; Monk JP Drugs; 1987 Oct; 34(4):411-37. PubMed ID: 3315624 [TBL] [Abstract][Full Text] [Related]
33. Bone and serum concentrations of five cephalosporin drugs. Relevance to prophylaxis and treatment in orthopedic surgery. Williams DN; Gustilo RB; Beverly R; Kind AC Clin Orthop Relat Res; 1983 Oct; (179):253-65. PubMed ID: 6617025 [TBL] [Abstract][Full Text] [Related]
34. Plasma and tissue concentrations of ceforanide and cefazolin in women undergoing hysterectomy. Souney PF; Fisher S; Tuomala RE; Polk BF; Simpson C Chemotherapy; 1988; 34(3):185-90. PubMed ID: 3416659 [TBL] [Abstract][Full Text] [Related]
35. Comparison of ceforanide and cephalothin prophylaxis in patients undergoing total joint arthroplasty. Soave R; Hirsch JC; Salvati EA; Brause BD; Roberts RB Orthopedics; 1986 Dec; 9(12):1657-60. PubMed ID: 3547369 [TBL] [Abstract][Full Text] [Related]
36. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model. Randolph JA; Buck RE; Price KE; Leitner F J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292 [TBL] [Abstract][Full Text] [Related]
37. Comment: Ceforanide half-life. Anderson PO Drug Intell Clin Pharm; 1985; 19(7-8):588-9. PubMed ID: 4028969 [No Abstract] [Full Text] [Related]
38. Ceforanide: in vitro and clinical evaluation. Burch KH; Pohlod D; Saravolatz LD; Madhavan T; Kiani D; Quinn EL; Del Busto R; Cardenas J; Fisher EJ Antimicrob Agents Chemother; 1979 Sep; 16(3):386-91. PubMed ID: 507795 [TBL] [Abstract][Full Text] [Related]
39. Antibiotic prophylaxis in open-heart surgery patients: comparison of cefamandole and cefuroxime. Peterson CD; Lake KD; Arom KV; Love KR Drug Intell Clin Pharm; 1987 Sep; 21(9):728-32. PubMed ID: 3498617 [TBL] [Abstract][Full Text] [Related]
40. [The effect of different autotransfusion procedures on the antibiotic picture. A study on cephalosporin cefamandole]. Menges T; Boldt J; Scholz K; Wagner RM; Ruwoldt R; Welters I; Hempelmann G Anaesthesist; 1993 Aug; 42(8):509-15. PubMed ID: 8368471 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]